You're Careful About Mold, Yet Still React. Here's Why.

GSTM1 is one of your liver’s primary detoxification enzymes. Its job is to grab mycotoxins, environmental pollutants, and oxidative waste products and mark them for elimination. It’s your cellular bouncer, deciding what stays and what goes.

The problem: roughly 50% of people carry a GSTM1 null genotype, meaning they inherited gene deletions from both parents and the enzyme is completely absent. Without it, your body loses a major pathway for eliminating mold byproducts and mycotoxins. You’re exposed to the same mold as everyone else, but your cells have half the clearance capacity.

What this feels like: brain fog that clears only when you leave the moldy space, persistent sinus inflammation even with air filtration, fatigue that seems disproportionate to the exposure, and a sense that your body is stuck in a low-grade inflammatory state whenever mold is present.

GSTP1 works alongside GSTM1 as your second major detox enzyme. While GSTM1 handles large environmental compounds, GSTP1 specializes in neutralizing reactive electrophiles and the oxidative damage that mycotoxins create inside your cells. Think of it as damage control at the molecular level.

The GSTP1 Ile105Val variant, carried by roughly 35-40% of people, reduces the enzyme’s activity by 30-50%. This means oxidative stress accumulates faster when you’re exposed to mold. Your cells start drowning in damage byproducts faster than you can eliminate them, even if you’re avoiding obvious mold sources.

What this feels like: headaches that seem to track with humidity or indoor air quality, joint and muscle inflammation that improves when you leave the building, difficulty concentrating in moldy spaces, and a sense that your body recovers more slowly after environmental exposures than it should.

Your mitochondria are your cells’ power plants. SOD2 is the guard stationed inside them, neutralizing free radicals before they damage the mitochondrial machinery. When SOD2 is working well, your cells stay energized even under stress. When it’s not, damage accumulates and energy production craters.

The SOD2 Val16Ala variant, present in roughly 40% of people with European ancestry, reduces the enzyme’s activity. Under normal conditions this is subtle. But when you’re exposed to mold and mycotoxins, oxidative stress inside your mitochondria spikes. Your energy production tanks because the protective system inside your cells can’t keep up with the damage.

What this feels like: profound fatigue that doesn’t respond to sleep, the sensation that your body has a ceiling on how much physical or mental exertion you can handle, post-exposure exhaustion that lingers for days, and a feeling that your energy improves noticeably in very clean air but crashes again in moldy spaces.

MTHFR catalyzes a critical step in the methylation cycle, the biochemical pathway your body uses to produce glutathione, repair DNA, manage inflammation, and eliminate heavy metals and mycotoxins. When MTHFR works well, your detox capacity is robust. When it doesn’t, your entire detoxification infrastructure becomes sluggish.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 35-70%. This ripples through your detox system. Less glutathione production. Slower heavy metal clearance. Reduced capacity to manage the oxidative stress that mold exposure creates. You lose the biochemical fuel that powers your body’s ability to neutralize mycotoxins.

What this feels like: mold sensitivity that worsens over time if you don’t intervene, a sense that your body accumulates toxins rather than clearing them, compounding fatigue and brain fog after repeated exposures, and symptoms that improve dramatically when you move to a very clean environment but return quickly in suboptimal air.

TNF is an inflammatory cytokine, a chemical messenger that tells your immune system to activate and mount a response. In appropriate doses, TNF is protective. But people with the TNF -308G>A variant produce higher levels of this cytokine, and their immune systems react more aggressively to threats, real or perceived.

Roughly 30% of people carry the A allele. When these people encounter mold, their immune system doesn’t simply recognize a trigger, it amplifies the response. Mast cells release histamine more aggressively. Immune cells produce more inflammatory signals. What should be a measured response becomes a full-scale inflammatory cascade. The same mold exposure that causes mild discomfort in others triggers significant inflammation in you.

What this feels like: sudden, disproportionate reactions to moldy spaces, symptoms that feel out of proportion to the actual exposure, whole-body inflammation including joint pain and muscle aches in addition to respiratory symptoms, and a sense that your immune system is hypervigilant and overreacting to environmental triggers.

HLA-DQ2 is a marker on your immune cells that determines how your body recognizes and responds to foreign antigens, including mold spores and mycotoxins. It’s like the fingerprint your immune system uses to identify threats. People with HLA-DQ2 present antigens differently, and their immune systems learn to respond more aggressively to fungal exposure.

HLA-DQ2 is present in roughly 30-40% of the general population, but prevalence varies significantly by ancestry. In people who carry HLA-DQ2, the immune system more readily mounts strong responses to mold antigens. This doesn’t mean you have celiac disease, but it does mean your immune system’s pattern recognition for fungal triggers is more sensitive. Your body treats mold as a bigger threat than it actually is, mounting disproportionate inflammation.

What this feels like: mold sensitivity that appears relatively suddenly, reactions that feel allergic in nature (itching, swelling, histamine release) even though standard allergy testing is negative or weak, seasonal patterns that correlate with humidity and mold spore counts, and relief when you move to very dry environments.